Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11325-11337
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11325
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11325
Figure 1 Flowchart of treatment of early esophageal squamous cell carcinoma in patients with cirrhosis.
ESTD: Endoscopic submucosal tunnel dissection; EESCC: Esophageal squamous cell carcinoma; EVL: Esophageal variceal ligation; TIPS: Transjugular intrahepatic portosystemic shunt.
Figure 2 Representative case with early esophageal squamous cell carcinoma treated with endoscopic submucosal tunnel dissection.
A: Esophageal lesions under white-light endoscopy; B: Esophageal iodine staining before dissection; C: Marking the margin of the esophageal lesions; D: Oral incision after submucosal injection; E: Tunnel creation by submucosal dissection; F: Submucosal dissection with an insulated tip knife; G: The wound after endoscopic submucosal tunnel dissection; H: The resected specimen was pinned on a board after iodine staining.
Figure 3 The flow diagram of cohort patients.
ESTD: Endoscopic submucosal tunnel dissection.
Figure 4 Kaplan-Meier survival curves for cirrhosis group and noncirrhosis group.
A: Overall survival; B: Disease-specific survival; C: Recurrence-free survival.
- Citation: Zhu LL, Liu LX, Wu JC, Gan T, Yang JL. Endoscopic submucosal tunnel dissection for early esophageal squamous cell carcinoma in patients with cirrhosis: A propensity score analysis. World J Clin Cases 2022; 10(31): 11325-11337
- URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11325.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11325